Profile
ADGM ABT BSX-PA BSX SYK MDT
Company Name Adagio Medical Holdings, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $25.23M $230.05B $175.45B $159.33B $148.97B $118.20B
Employees 0.08K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Todd Usen Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
ADGM ABT BSX-PA BSX SYK MDT
Quant Rating Score 1 4 1 3 3
Quant Rating Strong Sell Buy Strong Sell Neutral Neutral
Trading
ADGM ABT BSX-PA BSX SYK MDT
Last Close $1.635 $132.18 $122.18 $107.53 $388.56 $92.25
High 52 $4.59 $140.22 $122.18 $107.76 $403.53 $94.5
Low 52 $0.74 $111.1 $122.18 $81.37 $337.28 $79.61
Price vs. 52 Week High -64.38 % -5.73 % 0 % -0.21 % -3.71 % -2.38 %
Price vs. 52 Week Low 120.95 % 18.97 % 0 % 32.15 % 15.2 % 15.88 %
Total Return
ADGM ABT BSX-PA BSX SYK MDT
1 Month Return 19.69 % 1.73 % 0 % 0.69 % 1.85 % 2.91 %
3 Month Return 37.39 % -0.59 % 0 % 4.98 % 1.56 % 7.77 %
6 Month Return 55.71 % -3.92 % 0 % 3.78 % -0.35 % -0.84 %
9 Month Return -28.91 % 13.98 % 0 % 18.37 % -0.31 % 8.12 %
YTD Return 55.71 % 16.86 % 0 % 20.39 % 7.92 % 15.49 %
1 Year Return -64.38 % 15.54 % 0 % 31.2 % 7.84 % 1.34 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ADGM ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.76 % - - 0.85 % 3.05 %
Dividend Paid and Capex Coverage Ration (TTM) -73.17 % 1.45 % 3.96 % 3.96 % 2.2 % 1.31 %
Dividend Per Share (TTM) - 2.32 % - - 3.32 % 2.81 %
Payout Ratio (TTM) - 28.42 % 0.92 % 0.92 % 42.32 % 77.26 %
Growth
ADGM ABT BSX-PA BSX SYK MDT
Asset Growth 609.86 % 11.2 % 12.12 % 12.12 % 1.89 %
Gross Profit Growth -65.81 % 6.43 % 16.26 % 16.26 % 3.58 %
Revenue Growth -10.33 % 4.59 % 17.61 % 17.61 % 3.62 %
Revenue 3 Year 25.77 % -0.18 % 36.16 % 36.16 % 10.52 %
Revenue 5 Year - 34.24 % 47.52 % 47.52 % 20.96 %
Revenue 10 Year - 80.43 % 104.22 % 104.22 % 41.05 %
EBIT Growth -96.36 % 3.45 % 18.25 % 18.25 % 14.42 %
Net Income Growth -40.94 % 134.18 % 16.38 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share -934.33 % 94.27 % 72.31 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share -501202.18 % 271.11 % -62.7 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share -501202.18 % 410.99 % 1502.13 % 1502.13 % 48.51 %
Operating Income Growth -123.61 % 6.46 % 20.82 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) 37.67 % 17.86 % 37.24 % 37.24 % 3.79 %
Operating 3 Year CFG -4.55 % -16.72 % 77.55 % 77.55 % 0.13 %
Operating 5 Year CFG - 42.4 % 76.92 % 76.92 % 1.55 %
Operating 10 Year CFG - 102.79 % 143.61 % 143.61 % 22.45 %
EPS Growth 27.16 % 134.55 % 16.55 % 16.55 % 31.05 %
EPS Diluted Growth 27.16 % 133.64 % 16.25 % 16.25 % 30.8 %
Book Value Per Share 124.44 % 23.54 % 11.25 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share -81.94 % 36.46 % 26.58 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share 185765.4 % 56.53 % 48.35 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share 185765.4 % 92.83 % 186.31 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - - 128.74 %
Debt Growth -59.29 % -3.77 % 17.44 % 17.44 % 13.95 %
Free Cash Flow Growth 37.07 % 25.54 % 55.31 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
ADGM ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM -3388.1 % 52.92 % 63.23 % 63.23 % 62.19 % 63.44 %
Return on Assets TTM -169.63 % 16.64 % 6.23 % 6.23 % 6.3 % 5.12 %
Return on Equity TTM -207.11 % 29.93 % 11.77 % 11.77 % 14.08 % 9.62 %
Return on Capital Employed TTM -237.25 % 10.76 % 8.84 % 8.84 % 13.86 % 7.71 %
Net Income Per EBT TTM 103.64 % 176.99 % 83.43 % 83.43 % 87.08 % 82.32 %
EBT Per Ebit TTM 79.86 % 103.99 % 96.68 % 96.68 % 61.93 % 92.49 %
EBIT Per Revenue TTM -175069.67 % 17.62 % 16.77 % 16.77 % 22.72 % 17.9 %
Cash Flow To Debt Ratio TTM -154.74 % 67.25 % 32.56 % 32.56 % 25.04 % 24.98 %
Receivables Turnover TTM - 4.21 6.87 6.87 6.08 5.46
Payables Turnover TTM 1.11 4.71 6.77 6.77 6.25 4.89
Inventory Turnover TTM 0.8 2.92 2.37 2.37 1.7 -33.52
Fixed Asset Turnover TTM 1.55 % 378.32 % 481.99 % 481.99 % 560.03 % -6785.71 %
Asset Turnover TTM 0.12 % 51.32 % 46.07 % 46.07 % 51.41 % 37.59 %
Operating Cash Flow Per Share TTM -1.79 5.19 2.58 2.58 11.22 5.58
Free Cash Flow Per Share TTM -1.35 3.89 1.94 1.94 9.36 4.14
Cash Per Share TTM 53.31 % 418.4 % 49.04 % 49.04 % 644.69 % 633.66 %
Operating Cash Flow Sales Ratio TTM -65503.13 % 20.96 % 20.61 % 20.61 % 18 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 75.52 % 74.97 % 75.37 % 75.37 % 83.42 % 74.21 %
Cash Flow Coverage Ratios TTM -154.74 % 67.25 % 32.56 % 32.56 % 25.04 % 24.98 %
Price To Free Cash Flows Ratio TTM -1.21 33.96 54.76 55.46 41.65 22.29
Price To Operating Cash Flows Ratio TTM -0.92 25.46 41.18 41.71 34.73 16.54
Price Cash Flow Ratio TTM -0.92 25.46 41.18 41.71 34.73 16.54
Income Statement (TTM)
ADGM ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $-0B $21.33B $10.27B $10.27B $13.98B $21.91B
Gross Profit Ratio -620.07% 50.83% 61.31% 61.31% 61.87% 65.32%
EBITDA $-0.06B $10.83B $3.94B $3.94B $4.94B $9.22B
Net Income $-0.05B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -3.54 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
ADGM ABT BSX-PA BSX SYK MDT
Long Term Debt $0.02B $13.52B $9.37B $9.37B $12.57B $25.64B
Total Liabilities $0.03B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0.02B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.88B $6.75B
Total Debt $0.02B $15.28B $11.15B $11.15B $14.12B $28.52B
Total Assets $0.05B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
ADGM ABT BSX-PA BSX SYK MDT
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $-0.21B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.02B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 132.18
AEMD Aethlon Medical, Inc. 1.35
AFIB Acutus Medical, Inc. 0.0006
AHCO AdaptHealth Corp. 9.09
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 132.355
ALUR Allurion Technologies Inc. 2.12
AMIX Autonomix Medical, Inc. Common Stock 1.18
ANIK Anika Therapeutics, Inc. 9.01
AORT Artivion, Inc. 43.32
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.9
ARAY Accuray Incorporated 1.46
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 15.9
AVNS Avanos Medical, Inc. 12.35
AVR Anteris Technologies Global Corp. Common Stock 4.1
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 15.61
ETFs With Exposure to ADGM
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00003 204.32
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00003 155.01
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00003 155.02
VEMPX Vanguard Extended Market Index InstlPlus 0.00003 382.55
Unlock